Literature DB >> 32111364

Candida auris: report of an outbreak.

Carme Salvador García1, Nuria Tormo Palop2, Juan Vicente Mulet Bayona2, Mercedes Melero García3, David Navalpotro Rodríguez2, Manuel Belda Álvarez2, María Del Remedio Guna Serrano4, Concepción Gimeno Cardona4.   

Abstract

Candida auris is an emerging multidrug-resistant yeast that causes serious invasive infections and outbreaks with high mortality. Controlling C. auris is a challenge in which laboratories, clinicians and public health agencies are needed to identify and treat infections and prevent transmission. This review describes the general aspects of the biology, diagnosis and treatment of C. auris infection, as well as the main recommendations recently published by expert groups. We also present our experience of the C. auris outbreak at the Consorcio Hospital General Universitario de Valencia from September 2017 to August 2019. A total of 203 patients were colonised and/or infected by C. auris. Thirty invasive infections (29 blood cultures and one case of meningitis) were diagnosed. In all, 32% cases of candidemia were caused by C. auris in 2018. All strains were resistant to fluconazole.
Copyright © 2020. Publicado por Elsevier España, S.L.U.

Entities:  

Keywords:  Candida auris; Control; Emerging microorganisms; Microorganismo emergente; Multiresistance; Multirresistencia; Transmisión; Transmission

Mesh:

Substances:

Year:  2020        PMID: 32111364     DOI: 10.1016/j.eimc.2020.02.007

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  4 in total

1.  [Management of cutaneous and systemic involvement by Candida auris].

Authors:  C Roig Martí; J J Jiménez Sierra; I Pérez Catalán; S Gomila Sard; A Cardenal Álvarez; M D Bellés Medall
Journal:  Rev Esp Quimioter       Date:  2021-11-30       Impact factor: 1.553

2.  Successful control of Candida auris transmission in a German COVID-19 intensive care unit.

Authors:  Carl Hinrichs; Miriam Wiese-Posselt; Barbara Graf; Christine Geffers; Beate Weikert; Philipp Enghard; Alexander Aldejohann; Annette Schrauder; Andreas Knaust; Kai-Uwe Eckardt; Petra Gastmeier; Oliver Kurzai
Journal:  Mycoses       Date:  2022-04-24       Impact factor: 4.931

3.  Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital.

Authors:  Juan Vicente Mulet Bayona; Nuria Tormo Palop; Carme Salvador García; Begoña Fuster Escrivá; Mercedes Chanzá Aviñó; Pilar Ortega García; Concepción Gimeno Cardona
Journal:  J Fungi (Basel)       Date:  2021-05-31

4.  Novel Chromogenic Medium CHROMagarTM Candida Plus for Detection of Candida auris and Other Candida Species from Surveillance and Environmental Samples: A Multicenter Study.

Authors:  Juan Vicente Mulet Bayona; Carme Salvador García; Nuria Tormo Palop; Amparo Valentín Martín; Carmelo González Padrón; Javier Colomina Rodríguez; Javier Pemán; Concepción Gimeno Cardona
Journal:  J Fungi (Basel)       Date:  2022-03-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.